Ranitidine Withdrawal

Ranitidine Withdrawal is a pharmacotherapeutic event denoting the discontinuation of ranitidine due to safety concerns, primarily its contamination with the probable human carcinogen N-nitrosodimethylamine (NDMA), distinguishing it from other histamine-2 receptor antagonist discontinuations by its regulatory and public health context.

22

Publications

598

Citations

97

Authors

34

Institutions

Publications per year

2017–2026

3

Authors

97

  1. JR
    J Rask-Madsen

    University of Copenhagen, Denmark

    2 publications · 85 citations

    2

    h-index

  2. EE
    Emad El‐Omar

    University of Aberdeen, United Kingdom

    2 publications · 87 citations

    2

    h-index

  3. JR
    Jennifer R. Lightdale

    University Gastroenterology, United States

    1 publications · 25 citations

    1

    h-index

  4. EG
    Eran Goldin

    Hadassah Academic College, Israel

    1 publications · 12 citations

    1

    h-index

  5. CA
    Constantine Arvanitakis

    University of Kansas, United States

    1 publications · 22 citations

    1

    h-index

1–5 of 97

Venues

  1. PubMed

    Repository · 4 publications · 81 citations

    4

    h-index

  2. Gut

    3 publications · 162 citations

    3

    h-index

  3. Scandinavian Journal of Gastroenterology

    2 publications · 87 citations

    2

    h-index

  4. The American Journal of Gastroenterology

    AJG · 2 publications · 55 citations

    2

    h-index

  5. BMJ

    2 publications · 57 citations

    2

    h-index

1–5